- By Joergen Haisem
- (General Dispatch) – In view of the latent threat posed by the coronavirus, the United Kingdom, together with other nations, is moving forward with the development of the vaccine, after making some changes to achieve greater effectiveness in the organism.
- The specific objective that motivates the changes generated in the vaccine is due to the variation of the coronavirus, together with its immediate availability.
- The rapid progress of the vaccine modifications does not mean that quality, safety and confidence in the product are being left aside.
- The vaccine is being developed under the initial modality, but subject to virus mutations, the countries supporting the UK are: Singapore, Switzerland, Canada and Australia.
- In the first instance, the vaccine must meet high quality standards, as well as offering an aggressive response to the constant threats of virus variation.
- Of course, the relevant tests will be carried out by small groups of people to evaluate the effectiveness and scope of the new product.
- The news is released in the midst of a very uncertain scenario, as so far no hard evidence has been established about the new vaccine.
- However, several manufacturers are already preparing booster vaccines in response to the constant mutation of the virus in different nations.
Adittional Information:
Breitbart: UK, 4 nations fast-track review of modified COVID vaccines
